跳至主要内容
临床试验/NCT04017910
NCT04017910终止不适用

Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients

Sonavex, Inc.2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Sonavex, Inc.
入组人数
17
试验地点
2
主要终点
Safety Endpoint

研究概览

简要总结

This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis access.

详细描述

This is Stage 1 of a 2 stage protocol, targeting to enroll 60 patients in prospective, single arm, non-randomized, multi-center observational study to record objective data in patients undergoing upper extremity arteriovenous fistula construction with autologous tissue for the purpose of eventual hemodialysis access, in whom the EchoMark is placed at the site of vascular anastomosis. Follow-up visits include EchoSure and duplex imaging.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Patients presenting for upper extremity arteriovenous fistula construction with autologous tissue for the purpose of eventual hemodialysis access where the surgeon has selected EchoMark and EchoSure as the optimal method of vascular monitoring based on clinical assessment and plan
  • Patient is able to sign informed consent and able to participate in all testing associated with this clinical investigation
  • Women of childbearing potential have a negative pregnancy test

排除标准

  • Age <18 years old
  • Patient unable to sign informed consent
  • Patient participating in another investigational device or pharmacological study
  • Prisoner or patient from vulnerable populations as defined in 45 CFR 46.

结局指标

主要结局

Safety Endpoint

时间窗: 24 Weeks

Number of Subjects with Freedom from Serious Adverse Events (SAEs) during the EchoMark implantation procedure and sub-sequent post-operative period.

Performance: Data Collection

时间窗: 24 weeks

Data collection to verify accuracy

Performance Endpoint

时间窗: 24 Weeks

Data collection to understand the natural history of flow physiology in AV fistulas and classify the fistula that will fail.

次要结局

未报告次要终点

研究者

发起方
Sonavex, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验